Wordt geladen...
Population-based estimates of survival and cost for metastatic melanoma
BACKGROUND: Fewer than half of all patients with metastatic melanoma survive more than 1 year. Standard treatments have had little success, but recent therapeutic advances offer the potential for an improved prognosis. In the present study, we used population-based administrative data to establish r...
Bewaard in:
| Gepubliceerd in: | Curr Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Multimed Inc.
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608398/ https://ncbi.nlm.nih.gov/pubmed/26628865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2557 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|